Abstract
RATIONALE: Airway Hyperresponsivness (AHR) and airway obstruction, relieved by bronchodilators are one of the main characteristics of asthma. We aimed to evaluate bronchodilator responsiveness (BDR) by applying a short-acting β-agonist (SABA) after methacholine- and adenosine 5'-monophosphate (AMP)-induced bronchoconstriction, respectively.METHODS: Methacholine and AMP challenges were performed with 3 days of interval in 69 children with mild persistent to moderate asthma. They were followed up at the Allergy Clinic of Korea University Anam Hospital. Each provocation test was terminated when the FEV1 decreased by more than 20% of its baseline value. Fifteen minutes after SABA inhalation in the state of bronchoconstriction, BDR was evaluated by measuring the FEV1. Each subject was evaluated by serum total IgE, blood eosinophil counts and serum eosinophil cationic protein (ECP).RESULTS: BDR after methacholine challenge (30.7±18.0%) and AMP challenge (35.2±24.0%) showed no significant differences. BDR after AMP challenge showed a significant correlation with the serum total IgE, and blood eosinophil counts, and serum ECP, but not in the methacholine challenge.CONCLUSIONS: In asthmatic children, BDR after each methacholine and AMP provocation tests showed no differences. However, BDR after AMP challenge test showed a significant correlation with total IgE and blood eosinophilic inflammatory markers, compared to BDR after methacholine challenge test. RATIONALE: Airway Hyperresponsivness (AHR) and airway obstruction, relieved by bronchodilators are one of the main characteristics of asthma. We aimed to evaluate bronchodilator responsiveness (BDR) by applying a short-acting β-agonist (SABA) after methacholine- and adenosine 5'-monophosphate (AMP)-induced bronchoconstriction, respectively. METHODS: Methacholine and AMP challenges were performed with 3 days of interval in 69 children with mild persistent to moderate asthma. They were followed up at the Allergy Clinic of Korea University Anam Hospital. Each provocation test was terminated when the FEV1 decreased by more than 20% of its baseline value. Fifteen minutes after SABA inhalation in the state of bronchoconstriction, BDR was evaluated by measuring the FEV1. Each subject was evaluated by serum total IgE, blood eosinophil counts and serum eosinophil cationic protein (ECP). RESULTS: BDR after methacholine challenge (30.7±18.0%) and AMP challenge (35.2±24.0%) showed no significant differences. BDR after AMP challenge showed a significant correlation with the serum total IgE, and blood eosinophil counts, and serum ECP, but not in the methacholine challenge. CONCLUSIONS: In asthmatic children, BDR after each methacholine and AMP provocation tests showed no differences. However, BDR after AMP challenge test showed a significant correlation with total IgE and blood eosinophilic inflammatory markers, compared to BDR after methacholine challenge test.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
